NCT02843373View on ClinicalTrials.gov

Brain-Based Biomarkers in Response to TMS in MDD

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Major Depressive DisorderDepression
Interventions
DEVICE

TMS

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT02843373 - Brain-Based Biomarkers in Response to TMS in MDD | Biotech Hunter | Biotech Hunter